4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
"4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inhibitor of phosphodiesterases.
Below are MeSH descriptors whose meaning is more general than "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone".
Below are MeSH descriptors whose meaning is more specific than "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone".
This graph shows the total number of publications written about "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone" by people in Harvard Catalyst Profiles by year, and whether "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
Below are the most recent publications written about "4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone" by people in Profiles.
-
Effect of cyclic AMP on barrier function of human lymphatic microvascular tubes. Microvasc Res. 2008 May; 76(1):46-51.
-
Inhibition of PGI2 signaling by miconazole in vascular smooth muscle cells. Prostaglandins Other Lipid Mediat. 2006 Jul; 80(1-2):28-34.
-
The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Pharmacol Biochem Behav. 1999 Jan; 62(1):151-8.
-
Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur J Pharmacol. 1998 Nov 27; 362(1):1-8.
-
Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. J Neurochem. 1995 Sep; 65(3):1007-15.
-
Effects of peptides of the secretin-glucagon family and cyclic nucleotides on tyrosine hydroxylase activity in sympathetic nerve endings. J Neurochem. 1991 Feb; 56(2):400-6.
-
Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther. 1986 Nov; 239(2):411-5.
-
Methylisobutylxanthine blocks insulin antagonism of cAMP-stimulated glycogenolysis at a site distinct from phosphodiesterase. Evidence favoring an insulin-insensitive calcium release mechanism. J Biol Chem. 1986 Mar 25; 261(9):4002-7.
-
The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action. FEBS Lett. 1985 Jan 01; 179(1):7-11.
-
Site of insulin inhibition of cAMP-stimulated glycogenolysis. J Biol Chem. 1984 May 25; 259(10):6052-5.